Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02186262 : Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
AgesMin: 18 Years Max: 80 Years
Inclusion Criteria:

- Age: 18 to 80 years old

- Language spoken: Finnish or Swedish

- Performance status: Karnofsky score 70 or better or WHO performance status 2 or better

- Supratentorial primary malignant glioma (the diagnosis is based on radiological and
clinical grounds)

- Supratentorial recurrent glioma based on MRI and/or [11C]methionine PET imaging

- Patient is scheduled to either surgery or stereotactic biopsy

- Mental status: Patients must be able to understand the meaning of the study

- Informed consent: The patient must sign the appropriate Ethical Committee (EC)
approved informed consent documents in the presence of the designated staff

Exclusion Criteria:

- Prior medical history: Patient must have no history of serious cardiovascular, liver
or kidney disease

- Any psychiatric condition that compromises the subject's ability to participate in the

- Infections: Patient must not have an uncontrolled serious infection

- No contraindications for MRI (cardiac pacemaker, intracranial clips etc)

- Patient must not have claustrophobia with serious symptoms

- Pregnant or lactating women
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557